Sign in
4/A

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-036822

Options or other derivatives

  • CEO acquired 153,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Evans John M. CEO 2020-02-05 Grant or award · Stock Option (Right to Buy) +99,336 99,336 D
Evans John M. CEO 2020-02-05 Grant or award · Stock Option (Right to Buy) +53,964 53,964 D
Loading xslF345X03/doc4a.xml…